Private Ocean’s Zevra Therapeutics ZVRA Stock Holding History

Private Ocean’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-124	Closed	-$2K	–	630
2019 Q3	$2K	Hold	124	–	–	﹤0.01%	552
2019 Q2	$3K	Buy	+124	New	+$3.12K	﹤0.01%	409

Other funds holding ZVRA

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RFN

RDA Financial Network Akron, Iowa $459M AUM 24.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Private Ocean's ZVRA Position: Q4 2019 in Review

Private Ocean sold out of Zevra Therapeutics (ZVRA) in Q4 2019, closing a stake of 124 shares — an estimated $2K sold.

Private Ocean first reported a position in ZVRA in Q2 2019 and held it in 2 quarters. The position peaked at $3K in Q2 2019. 27 funds tracked by Wall St. Rank hold ZVRA as of Q4 2019.

Private Ocean reported no remaining Zevra Therapeutics position as of Q4 2019 after selling out during the quarter.
Private Ocean sold 124 Zevra Therapeutics shares in Q4 2019, an estimated $2K.
Private Ocean first reported a position in Zevra Therapeutics in Q2 2019 and held it in 2 quarters.
Private Ocean's Zevra Therapeutics position peaked at $3K in Q2 2019.
27 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q4 2019.

Based on Private Ocean's 13F filing for Q4 2019, filed 5 Feb 2020.